XIA Wenguang, AN Changqing, ZHENG Chanjuan, et al. [J]. Journal of Traditional Chinese Medicine2020, 61(5): 375-382.DOI: 10.13288/j.11-2166/r.2020.05.002.
Objective To investigate the clinical efficacy of integrated traditional Chinese and western medicine in the treatment of novel coronavirus pneumonia(COVID-19) by retrospectively analyzing the clinical records of 52 patients. Methods The data of patients with COVID-19 from Hubei Provincial Hospital of Integrated Traditional Chinese and Western Medicine during January 15 th
2020 to February 8 th
2020 were collected to investigate and analyze the basic information
traditional Chinese medical syndromes
laboratory tests and treatment methods. Patients were divided into two groups according to the intervention
a western medicine group of 18 cases treated with anti-virus
anti-infection and auxiliary supportive drugs
and an integrated treatment group of 34 cases treated with traditional Chinese medicine decoctions
patent Chinese medicines and traditional Chinese medicine injections in addition to the western medicine group. Clinical symptoms disappearance time
body temperature normalization time
accompanying symptom disappearance rate
average hospitalization days
clinical cure rate
and mortality rate were compared between groups. Results The 52 patients include 23 male patients and 29 female patients
the average age was(54.00±12.83) years old
and the time from onset to hospitalization was(7.44 ± 2.99) days. The main symptoms include fever(75%)
fatigue(61.5%)
cough(50%)
and other symptoms(34.6%). According to the conditions at the time of admission
there were 76.9% ordinary type
19.2% severe patients
and 3.8% critical patients. The main syndrome types in Chinese medicine were dampness-toxin stagnated in the lung(30.8%)
pestilence-toxicity blocking the lung(25.0%)
damp-heat accumulation toxin in the lung(21.2%)
pathogenic heat congesting in the lung(19.2%) and internal blockade and external collapse(3.8%). Laboratory testing showed the following results: lymphocytes percentage(18.53±11.01) %
serum amyloid A(111.65±76.98) mg/L
C-reaction protein(31.34±21.99) mg/L and erythrocyte sedimentation rate(22.60±15.65) mm/H. The clinical symptom disappearance time [(5.15±1.68) d]
body temperature recovery time [(2.64±1.31) d]
average hospitalization days [(7.38±2.06) d]
and Chinese medicine syndrome scale score [(13.29±3.79) points] of the integrated treatment group were significantly lower than those in the western medicine group(P<0.05 or P<0.01). When patients were discharged from hospital
the accompanying symptom disappearance rate(87.9%)
the clinical cure rate(91.2%)
and the incidence of common type patients developed to severe type(5.9%) in the integrated treatment group were significantly superior to those in the western medicine group(the corresponding results 38.9%
61.1%
and 33.3% respectively
P<0.05 or P<0.01). Conclusion The treatment of integrated Chinese and western medicine can significantly alleviate the clinical symptoms
shorten the course of disease and improve the cure rate
showing advantage to single use western medicine
which is worthy of clinical promotion and application.
Thinking on Qingfei Paidu Decoction (清肺排毒汤) for Quick and Effective Treatment of Novel Coronavirus Pneumonia Based on Syndrome Differentiation
Correlation Between the Periodization of Traditional Chinese Medicine and the Classification of Western Medicine in the Diagnosis and Treatment for Novel Coronavirus Pneumonia (Trial Version Fifth)
Thinking on Etiology and Pathogenesis of Novel Coronavirus Pneumonia in Traditional Chinese Medicine
新型冠状病毒肺炎中医临床特征与辨证治疗初探
Comprehensive Analysis of Diagnosis and Treatment Schemes for Prevention and Treatment of Novel Coronavirus Pneumonia by Traditional Chinese Medicine
Related Author
CHEN Xinyu
JIANG Qianqian
SONG Bin
ZHANG Hongchun
CHAO Enxiang
LI Demin
YANG Daowen
LI Xucheng
Related Institution
Hunan University of Chinese Medicine
The First Affiliated Hospital of Hunan University of Chinese Medicine
The Third Affiliated Hospital of Zunyi Medical University/The First People′s Hospital of Zunyi
Japan Friendship Hospital/National Clinical Research Center for Respiratory Disease
Guang’ anmen Hospital,China Academy of Chinese Medical Sciences